SOPH SOPHiA GENETICS SA IFRS
Services-Computer Processing & Data Preparation · Nasdaq · SEC CIK 1840706 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2025Q22025-06-30 | 2024Q22024-06-30 | 2023Q22023-06-30 | 2022Q22022-06-30 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $18.32M | $15.81M | $15.05M | $11.67M |
| Cost of revenue | $6.05M | $5.03M | $5.01M | $4.05M |
| Gross profit | $12.27M | $10.78M | $10.05M | $7.62M |
| R&D expense | $8.49M | $7.96M | $8.89M | $8.99M |
| SG&A expense | $12.30M | $10.58M | $14.04M | $14.70M |
| Operating income | -$18.49M | -$15.01M | -$20.05M | -$24.08M |
| Interest expense | $559,000 | $501,000 | — | — |
| Pretax income | -$21.65M | -$15.03M | -$21.32M | -$24.69M |
| Income tax | $762,000 | $161,000 | $73,000 | -$6,000 |
| Net income | -$22.41M | -$15.19M | -$21.40M | -$24.68M |
| EPS (basic) | -0.33 | -0.23 | -0.33 | -0.39 |
| EPS (diluted) | -0.33 | -0.23 | -0.33 | -0.39 |
| Weighted avg. shares (diluted) | 67.32M | 65.92M | 64.50M | 64.09M |
| Banking | ||||
| Net interest income | — | $450,000 | $1.13M | — |
| Balance sheet | ||||
| Cash & equivalents | $94.82M | $105.40M | $148.55M | $178.90M |
| Short-term investments | — | — | $0 | — |
| Receivables | $9.51M | $9.92M | $9.85M | — |
| Inventory | $6.22M | $6.54M | $5.46M | — |
| Current assets | $117.03M | $125.75M | $168.56M | — |
| PP&E, netmay include right-of-use assets (IFRS) | $5.14M | $6.13M | $7.68M | — |
| Intangibles | $33.73M | $27.43M | $22.82M | — |
| Total assets | $177.62M | $181.10M | $223.20M | — |
| Current liabilities | $34.48M | $28.61M | $31.55M | — |
| Long-term debt | $47.47M | $13.34M | — | — |
| Total debt | $47.47M | $13.34M | — | — |
| Total liabilities | $100.93M | $59.65M | $51.50M | — |
| Shareholders' equity | $76.69M | $121.44M | $171.70M | $228.12M |
| Net debt | -$47.36M | -$92.05M | — | — |
| Cash flow statement | ||||
| Operating cash flow | — | — | — | — |
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.